BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33273701)

  • 1. Impact of tobacco-related chronic obstructive pulmonary disease on developmental trajectories of comorbidities in the Taiwan population.
    Ho TW; Tsai YJ; Huang CT; Lien AS; Lai F
    Sci Rep; 2020 Dec; 10(1):21025. PubMed ID: 33273701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.
    López Varela MV; Montes de Oca M; Halbert R; Muiño A; Tálamo C; Pérez-Padilla R; Jardim JR; Valdivia G; Pertuzé J; Menezes AM;
    Arch Bronconeumol; 2013 Nov; 49(11):468-74. PubMed ID: 23856439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Major Comorbidities in Chronic Obstructive Pulmonary Disease Caused by Biomass Smoke or Tobacco.
    Golpe R; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añon O; Mengual-Macenlle N; Pérez-de-Llano L
    Respiration; 2017; 94(1):38-44. PubMed ID: 28456807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease in Taiwan.
    Liao KM; Chiu CC; Lu HY
    Respir Med; 2024 Jul; 228():107672. PubMed ID: 38763446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of peripheral arterial occlusive diseases in patients with chronic obstructive pulmonary disease: a nationwide study in Taiwan.
    Liao KM; Kuo LT; Lu HY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1455-1464. PubMed ID: 31308650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010-2012.
    Jo YS; Choi SM; Lee J; Park YS; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Lee CH
    Respir Med; 2015 Jan; 109(1):96-104. PubMed ID: 25434653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study.
    Huang KW; Luo JC; Leu HB; Lin HC; Lee FY; Chan WL; Lin SJ; Chen JW; Chang FY
    Aliment Pharmacol Ther; 2012 Apr; 35(7):796-802. PubMed ID: 22348540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery.
    Leavitt BJ; Ross CS; Spence B; Surgenor SD; Olmstead EM; Clough RA; Charlesworth DC; Kramer RS; O'Connor GT;
    Circulation; 2006 Jul; 114(1 Suppl):I430-4. PubMed ID: 16820614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes: A protective factor for COPD?
    Rayner LH; McGovern AP; Sherlock J; Gatenby P; Correa A; Creagh-Brown B; de Lusignan S
    Prim Care Diabetes; 2018 Oct; 12(5):438-444. PubMed ID: 29843977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.
    Rubinsztajn R; Przybyłowski T; Grabicki M; Karwat K; Maskey-Warzęchowska M; Batura-Gabryel H; Chazan R
    Adv Clin Exp Med; 2019 Mar; 28(3):319-324. PubMed ID: 30943332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
    Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
    Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comorbidities in COPD].
    de Miguel Díez J; García TG; Maestu LP
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study.
    Kaszuba E; Odeberg H; Råstam L; Halling A
    BMC Fam Pract; 2018 Nov; 19(1):178. PubMed ID: 30474547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
    Ozaltin B; Chapman R; Arfeen MQU; Fitzpatick N; Hemingway H; Direk K; Jacob J
    Respir Res; 2024 Jun; 25(1):249. PubMed ID: 38898447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Development of Diabetes after Subtotal Gastrectomy with Billroth II Anastomosis for Peptic Ulcer Disease.
    Chen CH; Hsu CM; Lin CL; Chou AK; Jeng LB
    PLoS One; 2016; 11(11):e0167321. PubMed ID: 27893867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort study.
    Chen WJ; Lin CC; Lin CY; Chang YJ; Sung FC; Kao CH; Yeh JJ
    COPD; 2014 Aug; 11(4):438-43. PubMed ID: 25010753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD in Taiwan: a National Epidemiology Survey.
    Cheng SL; Chan MC; Wang CC; Lin CH; Wang HC; Hsu JY; Hang LW; Chang CJ; Perng DW; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2459-67. PubMed ID: 26648708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity in COPD: Comorbidities with Practical Consequences?
    Zewari S; Hadi L; van den Elshout F; Dekhuijzen R; Heijdra Y; Vos P
    COPD; 2018 Oct; 15(5):464-471. PubMed ID: 30512982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.